Journey Medical Corporation Common Stock
DERMStock
$7.11−3.91%52W
Market Cap$200.18M
P/E—
Div yield—
Beta1.06
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-10.06%
Price vs S&P 500 (4W)12.70%
VGM Score55.22
Market Capitalization$200.18M
Earnings Surprise History
Q1 26-0.08est. -0.08
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.10
4.10
4.10
4.10
Industry Peers — Pharmaceuticals(563)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
DERMJourney Medical Corporation Common Stock | D | B | B | $7.11 |
| LLYEli Lilly & Co. | D | B | B | $1169.17 |
| JNJJohnson & Johnson | D | C | B | $249.97 |
| ABBVABBVIE INC. | D | C | B | $254.39 |
| MRKMerck & Co., Inc. | C | C | B | $127.63 |
| NVSNovartis AG | C | C | C | $152.73 |
| NVONovo-Nordisk A/S | C | B | C | $51.48 |
| AZNAstraZeneca PLC | C | B | C | $169.29 |
| ABTAbbott Laboratories | C | C | D | $98.83 |
| PFEPfizer Inc. | B | C | C | $25.14 |
| VRTXVertex Pharmaceuticals Inc | D | C | C | $486.03 |
About
Journey Medical Corp commercializes a portfolio of eight FDA-approved prescription drugs for dermatological conditions in the U.S. market. Key products include Qbrexza, Accutane, Amzeeq, and Exelderm, which treat various skin-related medical conditions. The company focuses on dermatological treatments for healthcare providers and patients.